Recent studies indicate that TP53 is mutated in approximately 75% of MPNST [7], while deletions of the CDKN2A gene, which codes for p16INK4A and p19ARF, are found in about 50% of neoplasms [8]. This evidence concerns the gene CDKN2A and malignant peripheral nerve sheath tumor.